A carregar...
Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
INTRODUCTION: Multi-marker molecular assays have impacted management of early stage breast cancer, facilitating adjuvant chemotherapy decisions. We generated prognostic models that incorporate protein-based molecular markers and clinico-pathological variables to improve survival prediction. METHODS:...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3096952/ https://ncbi.nlm.nih.gov/pubmed/20809974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2633 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|